Leerink Partners Reiterates Market Perform Rating on Amgen (AMGN), lowers estimates
Tweet Send to a Friend
Leerink Partners analyst David Risinger reiterated a Market Perform rating and $355.00 price target on Amgen (NASDAQ: AMGN)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
